Citius Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Trial of its Mino-Lok® Therapeutic to Salvage Catheters
Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has completed enrollment…
NRx Pharmaceuticals (Nasdaq: NRXP) to Present Keynote Address on Ketamine Efficacy and Risks at Upcoming Sachs Neuroscience Innovation Forum in San Francisco
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, (NRx), a clinical-stage biopharmaceutical company today announced that it has been selected to give the keynote address entitled “Ketamine for Suicidal Depression: The Benefits…
Regulus Therapeutics Announces Completion of Enrollment in Third Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the “Company” or “Regulus”), today announced it has completed enrollment in the third…
AnX Robotica Announces FDA Clearance for ProScan™: A Groundbreaking AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy
AnX Robotica, a pioneering force in advanced gastrointestinal visualization technologies, is excited to announce the FDA clearance of NaviCam ProScan™. Through the rigorous De Novo Submission Process, the FDA has…
Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca
Allorion Therapeutics (“Allorion”), a US and China-based biotechnology company that focuses on the discovery of new small molecule drugs for treating cancer and autoimmune diseases, has entered into an exclusive option…
MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to develop next-generation antibody drug conjugate in Oncology
MediLink Therapeutics (“MediLink”), announced today that it has entered into a worldwide collaboration and license agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY) on the development of a next-generation antibody-drug conjugate candidate…
Health Net Federal Services Earns Distinction with Renewed URAC Accreditations
Health Net Federal Services, LLC (HNFS), a Centene Corporation (NYSE: CNC) subsidiary, announced its renewed Utilization Review Accreditation Commission (URAC) accreditations in Health Network, Health Utilization Management, Case Management, and Disease Management. This achievement underscores HNFS’s…
Healing with the Rev LLC Introduces Pioneering Distance Healing Services for the Disenchanted
Healing with the Rev LLC, led by Reverend Teresa Heupel, announces its groundbreaking distance healing services, addressing the spiritual needs of those feeling estranged from traditional religious practices. In an era…
Newton Dentist Utilizes Oral Appliance Therapy to Treat Sleeping Disorders
Newton Dentistry provides a range of treatment options for snoring patients and sleep apnea patients. Dr. Yoon Ji Jang, who has experience in dental sleep medicine as well as sedation, provides…
The Inner Circle Acknowledges, Allan Lamb as a Pinnacle Platinum Healthcare Professional
Prominently featured in The Inner Circle, Allan Lamb is acknowledged as a Pinnacle Platinum Healthcare Professional for his contributions to the fields of General Surgery and Osteopathic Medicine. Dr. Lamb pursued higher…